Medical expert of the article
New publications
How is pollinosis in children treated?
Last reviewed: 06.07.2025

All iLive content is medically reviewed or fact checked to ensure as much factual accuracy as possible.
We have strict sourcing guidelines and only link to reputable media sites, academic research institutions and, whenever possible, medically peer reviewed studies. Note that the numbers in parentheses ([1], [2], etc.) are clickable links to these studies.
If you feel that any of our content is inaccurate, out-of-date, or otherwise questionable, please select it and press Ctrl + Enter.
For effective treatment of pollinosis, along with rational pathogenetic therapy, an important role is played by the regime of maximum possible limitation of the level of antigen stimulation. During the period of remission, the main and most effective method of treating patients with pollinosis is specific hyposensitization.
Pollen elimination is not possible.
Oral antihistamines
Name of the drug |
Release form |
Doses and frequency of administration |
|
Trading |
Generic (chemical) |
||
1st generation drugs |
|||
Diazolin |
Mebhydrolin |
Tablets of 0.05 and 0.1 |
Up to 2 years - 50-150 mg; from 2 to 5 years - 50-100 mg; from 5 to 10 years - 100-200 mg per day |
Peritol |
Cyproheptadine |
Tablets 0.004; syrup (1ml - 400 mg) |
From 6 months to 2 years (for special indications!) - 0.4 mg/kg per day; from 2 to 6 years - up to 6 mg per day; from 6 to 14 years - up to 12 mg per day; frequency of administration - 3 times per day |
Suprastin |
Chloropyramine |
Tablets 0.025 |
Up to 1 year - 6.25 mg; from 1 to 6 years - 8.3 mg; from 6 to 14 years - 12.5 mg per dose; frequency of administration - 2-3 times a day |
Tavegil |
Clemastine |
Tablets 0.001 |
From 6 to 12 years old - 0.5 - 1.0 mg; over 12 years old - 1 mg per dose; frequency of administration - 2 times a day |
Finestil |
Dimetindene maleate |
Drops for oral administration (1 ml = 20 drops = 1 mg); capsules 0.004 |
From 1 month to 1 year - 3-10 drops; from 1 year to 3 years - 10-15 drops; over 3 years - 15-20 drops per dose; frequency of administration 3 times a day; children over 12 years - 1 capsule 1 time per day |
Fenkarol |
Quinuclidil |
Tablets 0.01; 0.025 |
Up to 3 years - 5 mg; from 3 to 7 years - 10-15 mg; from 7 years and older - 15-25 mg per dose; frequency of administration 2-3 times a day |
Second generation drugs |
|||
Zaditen, ketof, astafen, etc. |
Ketotifen |
Tablets 0.001; syrup (1 ml = 0.2 mg) |
From 1 year to 3 years - 0.0005 mg; over 3 years - 0.001 mg per dose; frequency of administration - 2 times a day |
Zyrtec |
Cetirizine |
Tablets 0.01; drops 10 ml (1 ml = 20 drops = 10 mg) |
For children over 2 years old - 0.25 mg/kg, frequency of administration - 1-2 times a day |
Claritin |
Loratadine |
Tablets 0.01; syrup (5 ml = 0.005) |
For children over 2 years old and weighing up to 30 kg - 5 mg; with a body weight over 30 kg - 10 mg; frequency of administration - 1 time per day |
Third generation drugs |
|||
Telfast |
Fexofenadine |
Tablets 0.12-0.18 |
Children over 12 years old - 0.12 g or 0.18 g once a day |
Antihistamines are widely used in the treatment of all allergic diseases, and in particular pollinosis. First-generation antihistamines have a sedative and anticholinergic effect and can cause tachyphylaxis. However, these side effects are not observed in all patients. These drugs are effective in cases of severe itching and vagotonic autonomic dysfunction. Fenkarol and peritol have an antiserotonin effect. Dimedrol and pipolfen are currently almost never used in children due to the high risk of side effects.
Second-generation antihistamines do not penetrate the blood-brain barrier and do not have a pronounced sedative effect. They have a high affinity for H2 receptors, a rapid onset of action, a long-term therapeutic effect, without causing tachyphylaxis. In addition to selective inhibition of histamine H2 receptors, second-generation drugs inhibit the early and late phases of an allergic reaction, and have a combined antiallergic and anti-inflammatory effect. They are able to inhibit the release of histamine from mast cells and basophils, inhibit the production and release of leukotrienes, the formation of adhesion molecules of different classes, slow the flow of calcium into the cell, and the activation of eosinophils and platelets.
The third-generation antihistamine Telfast does not have the cardiotoxic effect characteristic of some second-generation drugs, is not subject to biotransformation in the liver and, therefore, does not interact with other drugs metabolized in the liver by the cytochrome P450 system. The antihistamine effect begins after 1 hour, reaches a maximum after 6 hours and lasts for 24 hours. The drug is used prophylactically during the flowering season of etiologically significant plants. Telfast, Zyrtec and Claritin are prescribed once a day.
Treatment of allergic rhinitis symptoms is described in the chapter on allergic diseases of the respiratory tract. For allergic conjunctivitis, use opticrom, cromogling (a solution of cromoglicic acid for eye drops).
Specific immunotherapy (SIT) is used in patients with polyvalent pollen sensitization (e.g., trees and grasses-weeds) who require long-term daily antihistamines and topical treatment of rhinitis and conjunctivitis symptoms. SIT can prevent the transformation of hay fever into more severe forms of respiratory allergy.
Climate therapy with a change in geographic zone for the flowering season of causative plants is shown.